The state is refusing so far to give clear information on the current proportion of events that are breakthrough. We are doing our best to figure out the reporting lag. In the meantime, Dave Dixon and I thought even the date of report data can help with trend identification. This chart is wonderful and shows for each week that the state has been reporting breakthrough events, the proportion that those breakthrough events represent of all events. You can see the rates over time and rate of change in those rates. The second version attempts to remove the age 12 and under group, since they are not eligible for vaccines and there therefore cannot be breakthrough events in that age group. Changes the percents a little. Remember that the state is doing the best it can to drag its feet on identifying breakthrough events and is unable to fully account for who really is vaxed, so these are undercounts in all likelihood.
Another Way to Look at Breakthroughs, October 7
No Comments
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
May 7, 2024
Venture Capital in 2023
The venture capital community is still struggling with exits and poor investments.
Commentary
May 6, 2024
Drug Spending and Pricing
US drug spending remains high, with more expensive drugs continuing to come on the market…
Commentary
May 4, 2024
Too Much Research on Everything, So Some Quick Hits, First on Climate
I have too much stuff sitting around so just going to try to quickly clear…